Related Experiment Video

Updated: Apr 20, 2026

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

34.3K

Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes

Steffen Durinck1,2, Eric W Stawiski1,2, Andrea Pavía-Jiménez3,4,5

  • 1Molecular Biology Department, Genentech, Inc., South San Francisco, California, USA.

Nature Genetics
|November 18, 2014
PubMed

Insights

This study reveals key molecular differences in kidney cancer subtypes, identifying novel gene mutations and fusions in papillary and chromophobe renal cell carcinomas. Findings suggest BIRC7 as a potential therapeutic target for MiTF-high kidney tumors.

Area of Science:

  • Genomics
  • Oncology
  • Molecular Biology

Background:

  • Kidney cancer comprises diverse subtypes with distinct molecular profiles.
  • Understanding these distinctions is crucial for targeted therapies.
  • Non-clear cell renal cell carcinomas (nccRCCs) include papillary, chromophobe, and translocation subtypes.

Purpose of the Study:

  • To elucidate the molecular characteristics of renal oncocytomas and nccRCC subtypes.
  • To identify novel genetic alterations and gene expression patterns.
  • To explore potential therapeutic targets in kidney cancer.

Main Methods:

  • Analysis of exome, transcriptome, and copy number alteration data from 167 primary human tumors.
  • Identification of significantly mutated genes using next-generation sequencing.
  • Gene expression profiling and RNA sequencing for fusion detection.

Main Results:

  • Ten significantly mutated genes identified in papillary renal cell carcinoma (pRCC), including novel MET mutations.
  • TP53, PTEN, and others identified as significantly mutated in chromophobe renal cell carcinoma (chRCC).
  • A five-gene signature for molecular classification of chRCC, renal oncocytoma, and pRCC.
  • Discovery of novel gene fusions, such as ACTG1-MITF, driving cellular transformation.
  • Upregulation of anti-apoptotic BIRC7 in MiTF-high kidney cancer.

Conclusions:

  • Distinct molecular landscapes exist across kidney cancer subtypes.
  • Novel mutations and gene fusions contribute to kidney cancer pathogenesis.
  • BIRC7 inhibition presents a potential therapeutic strategy for specific kidney cancer subtypes.

More Related Videos

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

9.6K
Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.4K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K